Gregory Rauscher, MD
Plastic and Reconstructive Surgery · Hackensack, NJNPI 1346244159
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $2,311 of the $3,290 with a category attached, or 70.2%. AbbVie accounts for 71.9% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2021 at $1,371 and has fallen 97.9% since, to $29 in 2025.
Across 65 payments — averaging $50.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Smith+Nephew$437
- Endo Pharmaceuticals Inc.$156
- Polarityte, Inc.$139
- Axogen$72
- Integra Lifesciences Corporation$54
- plus $67 from 4 others
What the payments were for
- Speaking & faculty fees$2,31170%
- Food & beverage$97930%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 22 | $2,365 |
| Smith+Nephew | 20 | $437 |
| Endo Pharmaceuticals Inc. | 11 | $156 |
| Polarityte, Inc. | 2 | $139 |
| Axogen | 4 | $72 |
| Integra Lifesciences Corporation | 2 | $54 |
| Angiodynamics, Inc. | 1 | $20 |
| Next Science LLC | 1 | $18 |
| LEO Pharma Inc. | 1 | $15 |
| Pacira Pharmaceuticals Incorporated | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SkinTE$112
How this compares
$3,290 in reported general payments places this provider in the 70th percentile of 93 plastic and reconstructive surgery providers in New Jersey.
See all plastic and reconstructive surgery providers in New Jersey →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluorouracil | 13 | $904 |
| Clobetasol Propionate | 12 | $276 |
| Azithromycin | 17 | $240 |
| Doxycycline Hyclate | 24 | $168 |
| Cephalexin | 16 | $93 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 22 | $88 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Hackensack
- Kari ColenHackensack$5K
- Sara ColeCherry Hill$63K
- Edward LeeRahway$50K
- Eric ChangFlorham Park$41K
- Colin FaileyFlorham Park$40K
- Steve FallekEnglewood$34K
- Barry DibernardoMontclair$31K
- Michael NagyManasquan$27K
- John TaylorRed Bank$18K
- Francisco ColonFlorham Park$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.